“D” is for Diagnosis: Decoding a Difficult Thoracic Malignancy—Piecing Together a Rare Diagnosis, Preparing for Tomorrow’s Treatments

Release Date: February 4, 2026

Expiration Date: February 4, 2027

Activity Overview

Despite increasing awareness and new therapeutic options, malignant pleural mesothelioma (MPM) remains difficult to diagnose and manage. Nonspecific symptoms, imaging overlap, and variable biopsy yield contribute to delayed identification, while evolving immunotherapy (IO)-based strategies require thoughtful patient selection and coordinated multidisciplinary care.

This webcast immerses learners in an interactive case that simulates real diagnostic challenges, followed by a discussion that translates findings into practical management. Expert faculty highlight how to streamline diagnostic workflows, apply current first-line IO-IO and IO-chemotherapy options, and anticipate emerging approaches, including bispecific antibodies. The program equips clinicians with concise, actionable strategies to improve timely diagnosis and evidence-based treatment of MPM.

Target Audience

This educational activity is directed toward medical oncologists, pulmonologists, advanced practice providers, nurses, pharmacists, and other health care practitioners who manage patients with mesothelioma.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Apply a structured algorithm for patient evaluation, including selection of appropriate immunohistochemistry/ancillary tests, to accurately diagnose malignant pleural mesothelioma (MPM)
• Evaluate new evidence supporting frontline options and emerging therapies for MPM
• Integrate the latest data into personalized treatment plans based on patient characteristics
• Describe roles of the multidisciplinary care team in the collaborative management of MPM

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.